Pharma & Biotech

A significant strategic transition is underway at Mainz-based biotechnology firm BioNTech. While news of the impending departure of its two...

A key medical authority has broadened its treatment recommendations for bladder cancer, providing a notable boost for ImmunityBio's commercial prospects....

A new research report from Canaccord Genuity triggered a significant rally for Ocugen Inc. on Tuesday. The firm initiated coverage...

A significant strategic pivot by telehealth provider Hims & Hers has prompted a swift reassessment from Wall Street. The company...

New preclinical findings for Anavex Life Sciences' lead drug candidate, Blarcamesine, were unveiled at the AD/PD 2026 conference in Copenhagen....

The strategic direction for Neutra has undergone a significant change, with its core emphasis now placed squarely on the clinical...

Having secured U.S. approval for its gene therapy Vyjuvek, Krystal Biotech is now executing a deliberate strategy to capture international...

The global diagnostics industry is undergoing a significant strategic realignment. At the heart of this shift is a focus on...

Pharmaceutical giant Pfizer is actively working to secure its future revenue streams as the patent expiration for its blockbuster drug...

Evotec SE has announced a sweeping operational overhaul, sending its stock price lower as the market digested a sharply reduced...